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Abstract
Fragile X associated disorders are caused by a premutation allele in the fragile X mental retardation 1 gene (FMR1) and are
hypothesized to result from the toxic effect of elevated levels of expanded FMR1 transcripts. Increased levels of FMR1 mRNA
have indeed been reported in premutation carriers; however the mechanism by which expanded alleles lead to elevated
levels of FMR1 mRNA in premutation carriers is unknown. Within the CGG repeat tract AGG interruptions are found,
generally 1–3 present in normal/intermediate alleles (6–54 CGG repeats) and usually 0–1 in premutation alleles (55–200 CGG
repeats). They are present at specific locations, generally occurring after 9 or 10 uninterrupted CGG repeats
[(CGG)9AGG(CGG)9AGG(CGG)n]. We evaluated both the number of AGG interruptions and the resulting length of the
uninterrupted 39 CGG repeat pure tract in premutation alleles derived from two large cohorts of male and female carriers to
determine whether the presence of AGG interruptions or the length of a pure stretch of CGG repeats influence the levels of
FMR1 mRNA in blood. Our findings indicate that neither the number of AGG interruptions, nor their position along the CGG
tract have a significant affect on mRNA levels in premutation carriers. We also, as expected based on previous findings,
observed a highly significant correlation between CGG repeat number (as both total length and length of pure CGG stretch)
and FMR1 mRNA expression levels, in both males and females. Importantly, we did not observe any significant difference in
FMR1 mRNA levels in premutation carriers based on age.
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Introduction
Expansion of the CGG trinucleotide repeat in the 59
untranslated (UTR) region of the FMR1 gene is causative for a
number of disorders including fragile X syndrome (FXS), fragile X
associated tremor ataxia syndrome (FXTAS) and FMR1 related
primary ovarian insufficiency (FXPOI) [1]. A CGG expansion in
the FMR1 gene has also been associated with an increased
incidence of several other clinical involvements ranging from
anxiety to autism spectrum disorder (ASD) [2]. The length of the
repeat falls into several categories, defined by The American
College of Medical Genetics [3], which are useful as molecular
indicators and based on predicting the risk of expansion in the next
generations. Individuals with an allele within the normal range (5–
44 CGG repeats) are considered unaffected, while full mutation
alleles (.200 CGG repeats) result in transcriptional silencing of
the FMR1 gene, absence of fragile X mental retardation 1 protein
(FMRP) and fragile X syndrome. Intermediate (45–54 CGG
repeats) and premutation alleles (55–200 CGG repeats) were
originally characterized as having an increased risk of expansion in
future generations, but having no phenotypic effect on the carrier
of these alleles. Within the last decade, biological effects have been
identified and studied [4,5,6], but more needs to be learned about
the mechanism that leads to the clinical involvement in these
transitional ranges.
Increased levels of FMR1 mRNA correlating with the length of
the repeat tract, have been reported in both male and female
carriers of a premutation allele [7,8,9]. Although the elevated
levels result from an increase in transcriptional activity [10] a
concomitant decreased protein expression, due to a deficit in
translational efficiency especially in longer expanded alleles, was
also reported [7,8,9,11,12]. Recently, increased FMRP expression
levels have been reported in premutation carriers with an allele
within the 80–89 CGG repeats range compared to those in the
lower and in the higher premutation range [12].
Within the CGG repeat tract are interspersions of AGG
segments that occur in normal, intermediate, and premutation
range alleles and commonly occur after 9 or 10 uninterrupted
CGG repeats [(CGG)9AGG(CGG)9AGG(CGG)n]. These AGG
interruptions can be stably inherited, such that the number of
AGG interruptions and their position is likely to correspond in
parent and offspring; however like the length of CGG repeat tracts
in FMR1, there is a level of instability, such as the loss of an
interruption during transmission [13].
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the stability of the repeat tract during maternal transmission by
decreasing the size of pure CGG repeats in the tract [14,15]. AGG
interruptions have been shown to affect both DNA and RNA
structure at the FMR1 locus. The DNA at a pure CGG repeat
tract of FMR1 has been shown to adopt a non-ß conformation,
which is increasingly unstable in the presence of AGG interrup-
tions and leads to the formation of bulges and larger loops [16].
The CGG repeat region is known to form secondary structures in
DNA, such as hairpins and tetraplexes, and in RNA has also been
shown to form hairpins, though tetraplexes were not observed
[16].
In recent studies, the presence of AGG interruptions within
the FMR1 trinucleotide repeat has been investigated to
determine if transcription or translation is affected [10,12,17].
Tassone et al. [10] looked at the effect of AGG interruptions on
FMR1 transcription levels and reported a lack of association
between FMR1 mRNA levels and the number of AGG
interruptions in 147 subjects including 76 subjects with normal
range alleles, 10 subjects with an intermediate allele and 59
subjects with a premutation allele. More recently, Peprah et al.
[12] looked at the transcriptional and translational activity of
FMR1 and AGG interruptions in 74 premutation carriers and
found no correlations, confirming previous findings from an in
vitro system [17].
Here, we describe our results from an in-depth investigation of
the influence of the number of AGG interruptions, their location
within the CGG tract and the length of the 39 CGG repeat pure
tract on the level of FMR1 mRNA in a cohort of 770 premutation
carriers, including 288 males and 482 females. This study adds to
the body of knowledge with an increased sample size for male
participants and confirms the same findings in a cohort of female
participants, which have not been previously studied. Additionally,
using a new triple primer PCR, we have been able to precisely
map AGG interruptions along the CGG repeat tract and to
correlate their location with the FMR1 mRNA transcriptional
level. This new approach allowed us to analyze both the total
length of the repeat region and the length of uninterrupted CGG
repeats (a 39 CGG repeat pure stretch). Previous analysis of the
role AGG interruptions have on transcription may have been
unable to detect a significant correlation because the analysis was
based on the presence or the absence of AGG interruptions, but
not on the number of uninterrupted CGG repeats.
Results
DNA samples from 770 unrelated individuals comprising 288
males and 482 females were selected for a detailed molecular
analysis including CGG repeat number, length of pure CGG
stretch, activation ratio in females, AGG number and distribution,
and FMR1 mRNA expression levels. Males and females with the
premutation were selected from fragile X pedigrees because they
were known to carry the premutation (and confirmed by FMR1
DNA testing). None were selected on the basis of clinical
symptoms.
Of the 770 samples, 265 male and 435 female samples had
measured mRNA transcript levels and 231 male and 397 female
samples had information about the age of the participant at the
time the DNA and RNA samples were collected in males and
females respectively.
The mean age in male subjects at the time of sample collection
was 45.8 years (626.3), and the mean age of female subjects was
42.6 years (616.8). Most of the female premutation carriers were
identified consequent of having a child with FXS and male
premutation carriers were part of projects focused on fragile X
associated disorders (distributions included in Figure S1a,b).
The mean FMR1 mRNA level in males (3.161.2) was
significantly different from the mean in the females (2.460.8) (t
test P,0.001) due to the contribution of the normal allele on the
other X chromosome (Table 1; distributions are presented in
Supplementary Material (Figure S2a,b). CGG repeat allele sizes
were comparable between males (mean 93.1625.8) and females
(89.2620.7) (t test P=0.035) (Figure S3a,b). The distribution of
Activation ratio measured in 465 females had a mean of 0.54 and
followed a normal distribution (Figure 1). Detailed molecular
measures are presented in Table 1.
Of the 288 male samples, 23 had missing data on FMR1 mRNA
levels, 6 were missing the number of AGG interruptions and
length of the longest pure CGG stretch, and 57 samples were
missing participant age at time of sample collection. Missing
observations were excluded from analyses as needed. The FMR1
mRNA level from one additional sample was excluded from
analyses due to an excessively large standard error of replicate
measurements.
Of the 482 female subjects with the FMR1 premutation allele
included in the study, 47 samples had no data on FMR1 mRNA
levels, 17 samples did not have the activation ratio, and 85 samples
were missing data on the participant age at time of sample
collection. Missing observations were excluded from analyses as
needed. The FMR1 mRNA levels in females are determined by
two alleles. In this study one allele was within the premutation
range and the other was within the normal range (with the
exception of 2 subjects, one with 2 premutation alleles and one
with an intermediate and a premutation allele). Adjusted FMR1
mRNA levels (estimates of mRNAhp, the contribution to the
observed mRNA level from expanded alleles) were derived from
the observed FMR1 mRNA level and the activation ratios using
the method described in Tassone et al. [9].
FMR1 mRNA levels correlate with both total CGG repeat
length and the length of 39 pure CGG stretch in male and
female carriers
In order to assess the relationship between FMR1 mRNA levels
and total CGG length, a linear regression model, with FMR1
mRNA level as the response variable and total CGG length (as a
Table 1. A comparison of age, CGG repeat size, and FMR1
mRNA levels in male and female premutation carriers.
Male Female
Samples (N) 288 482
Mean age 48.8 42.6
Age range 1–89 1–95
Mean Total CGG length (standard deviation) 93.1 (25.8) 89.2 (20.7)
Total CGG size range 55–220 55–190
Mean 39 pure CGG stretch 84.9 82.6
39 Pure CGG range 34–220 35–190
Number of AGG interruptions range 0–2 0–3
Mean FMR1 mRNA levels 3.1 2.4
FMR1 mRNA levels 1.1–9.0 0.8–6.4
Mean activation ratio 0.54
Activation ratio range 0.08–0.96
doi:10.1371/journal.pone.0021728.t001
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subsequent analysis was conducted separately on data from males
and females. Based on the linear regression model fit using total
CGG length as a continuous variable, FMR1 mRNA levels appear
to be strongly related to total CGG length (P,0.001) in both males
(Figure 2a) and females (Figure 2b) confirming previous reports
[7,8,9,10,12].
In order to assess the relationship between FMR1 mRNA levels
and length of 39 pure CGG stretch the same analyses were
conducted. Using a linear regression model, with FMR1 mRNA
level as the response variable and length of pure CGG stretch (as a
continuous variable) as the predictor, FMR1 mRNA levels appear
to be strongly related to the length of 39 pure CGG stretch
(P,0.001) in both males (Figure 3a) and females (Figure 3b).
FMR1 mRNA levels were adjusted for activation ratio. Results
were confirmed using an ANOVA model, with FMR1 mRNA
level as the response variable and length of pure CGG stretch as
the predictor.
The number of AGG Interruptions correlate with total
CGG Length
The relationship between total CGG length and number of
AGG interruptions was assessed using an ANOVA model, with
total CGG length as the response variable and number of AGG
interruptions as the predictor. The test for an AGG effect was
highly significant (P,0.001) in both genders, rejecting the null
hypothesis that mean total CGG length is equal in each AGG
group. Tukey HSD post-hoc tests were conducted in order to test
for pairwise differences between each group. In males, the total
CGG length differed significantly between subjects with 0
interruptions and those with 1 or 2 interruptions (P,0.001 in
both cases). However, the data did not suggest a difference in total
CGG length between subjects with 1 AGG interruption and those
with 2 AGG interruptions (P=0.940). A box plot of total CGG
length for each number of AGG interruptions is shown in
Figure 4a. In females, the total CGG length differed significantly
between subjects with 0 and 1 interruption (P=0.001) and
between those with 0 and 2 interruptions (p,0.001). However, the
data did not suggest a difference in total CGG length between the
remaining pairs of groups (note that this lack of significance should
be interpreted cautiously for comparisons between patients with 3
interruptions and those with other numbers of interruptions due to
the small sample size). A box plot of total CGG length for each
number of AGG interruptions is shown in Figure 4b. Finally, no
difference was observed in the interspersion pattern of AGG
interruptions within the premutation alleles as already reported
[13].
FMR1 mRNA Levels do not correlate with the number of
AGG interruptions
The relationship between FMR1 mRNA levels and number of
AGG interruptions was assessed using an ANOVA model, with
FMR1 mRNA level as the response variable and number of AGG
interruptions as the predictor. The global test for an AGG effect
Figure 1. Distribution of activation ratio. Activation ratio was determined by Southern blot analysis. The distribution approximates a normal
distribution with a mean of 0.54.
doi:10.1371/journal.pone.0021728.g001
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the AGG groups (P=0.060 in males and P=0.066 in females)
(Figure 5a,b). These findings confirmed previous reports [10].
Given that the total CGG length, which is highly predictive of
FMR1 mRNA levels, differs significantly between subjects with
different number of AGG interruptions, further analyses were
conducted in which a separate linear regression of FMR1 mRNA
levels on total CGG length was fitted for each number of AGG
interruptions. Differences in the intercepts of these lines would
suggest differences in FMR1 mRNA levels between subjects with
different numbers of AGG interruptions but comparable total
CGG length, whereas differences in the slopes of these lines would
Figure 3. Scatterplot of FMR1 mRNA levels by length of CGG pure stretch. A linear regression model with model fit using CGG pure stretch
as a continuous variable a) in premutation males and b) in premutation females. FMR1 mRNA levels appear strongly related to pure CGG stretch
(P,0.001).
doi:10.1371/journal.pone.0021728.g003
Figure 2. Scatterplot of FMR1 mRNA levels by total CGG length. A linear regression model with model fit using CGG length as a continuous
variable a) in premutation males and b) in premutation females. FMR1 mRNA levels show strong (P,0.001) correlation to total CGG length.
doi:10.1371/journal.pone.0021728.g002
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levels differs based on the number of AGG interruptions. In male
subjects, the slope of the regression line fitted to data from subjects
with 0 AGG interruptions showed a marginally significant
difference from the slope of the regression line fitted to data from
subjects with 1 interruption (P=0.046); no other significant
differences in slopes or intercepts of regression lines were seen
for male or female subjects. (Analyses on data from female subjects
Figure 4. A box plot of total CGG length for each number of AGG interruptions. A) In premutation male data, significant difference in total
CGG length of subjects with no AGG interruptions (130 subjects) and those with 1 or 2 interruptions (96 and 55 subjects respectively) was found
(P,0.001 in both cases). No significance was found in total CGG length of subjects with 1 AGG interruption compared to 2 AGG interruptions
(P=0.935). B) Premutation female data showed significant difference in total CGG length of subjects with no AGG interruptions (259 subjects) and
those with 1 or 2 interruptions (143 and 78 subjects respectively) (P,0.001) but no difference with remaining pairs.
doi:10.1371/journal.pone.0021728.g004
Figure 5. A box plot of FMR1 mRNA levels for each number of AGG interruptions. No difference was found in FMR1 mRNA levels between
any of the AGG interruption groups a) in males (P=0.060) or b) females (P=0.066).
doi:10.1371/journal.pone.0021728.g005
Association between AGG and Transcription
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interruptions into a single category.) When controlling for total
CGG length, the number of AGG interruptions does not appear to
have a meaningful impact on FMR1 mRNA levels for both
genders. (Figure 6a,b; and Table 2)
FMR1 mRNA levels are not affected by age
The relationship between FMR1 mRNA and age, controlling
for CGG, was assessed using a linear regression model, with FMR1
mRNA level as the response variable and total CGG length
(continuous) and age as predictors. Although the total CGG length
remains strongly predictive of FMR1 mRNA levels when age is
included in the model (P,0.001) for both genders, our data do not
suggest a statistically significant relationship between FMR1
mRNA levels and age in either males or females when CGG is
controlled (P=0.100 in males and P=0.297 in females). The
scatter plots of FMR1 mRNA levels by age are shown in
Figure 7a,b.
Discussion
Premutation alleles (55–200 CGG repeats) are relatively
common in the general population with a prevalence of
approximately 1 in 113–259 females and 1 in 251–813 males
[13,18,19,20,21]. Although individuals with the premutation were
previously thought to be clinically unaffected, it has become clear
in the past decade that premutation carriers present with a
number of clinical involvement including the fragile X-associated
primary ovarian insufficiency (FXPOI) in approximately 20% of
the females [22,23,24] and the fragile X-associated tremor ataxia
syndrome (FXTAS) [25,26,27,28] which occurs in approximately
1/3 of the male carriers and less frequently in female carriers. In
addition, a variety of medical and developmental problems
including ADHD and autism spectrum disorders (ASD) [29,30]
and psychiatric and emotional problems [31,32,33,34], most
notably depression and anxiety, are also commonly seen in
premutation carriers. Psychological problems have been demon-
strated to be significantly associated with an increased level of the
FMR1 mRNA [32] commonly observed in premutation carriers
[7,8,9]. The increased levels of FMR1 mRNA has led to the RNA
gain- of- function model in which the FMR1 mRNA itself is
causative of the clinical problems observed in carriers, including
FXTAS. Consistent with the mRNA toxicity model and the
neurodegeneration associated with FXTAS, murine hippocampal
neurons from CGG expanded neurons show reduced viability and
display deficit in dendritic complexity including shorter dendritic
length and fewer branches between 7 and 21 day compared to
wild type age matched controls [35]. This provides evidence that
disorders associated with the premutation genotype are the result
of a global increase in FMR1 mRNA levels that starts early in life.
Our data showing no significant age-dependence on FMR1
transcriptional levels is in agreement with these findings.
Although it has been demonstrated that the FMR1 transcription
rate, not the stability of the message, is increased in premutation
alleles [9,10] the mechanism by which this phenomena occurs has
not been clarified yet. Thus, we have studied the potential role of
AGG interruption and length of the 39 CGG repeat pure stretch in
a large cohort of male and female carriers of the FMR1
premutation. Our findings indicate that FMR1 transcription levels,
which are elevated in premutation carriers, are not significantly
altered by the presence or by the position of AGG interruptions.
This comprehensive analysis compared the number of AGG
interruptions within a premutation allele and FMR1 mRNA levels
and found significant difference between groups of AGG
interruptions when the total length of the CGG tract was factored
in. Genders were analyzed separately, adjustments were made for
activation ratio in females, each gender comparison resulted in no
correlation. These results are consistent with previous studies that
Figure 6. Scatterplot of FMR1 mRNA levels by total CGG length. A linear regression model showed no significant difference in the slopes for 0,
1, or 2 AGG interruptions a) in males (P.0.046) or b) females (P.0.448). See also Table 2.
doi:10.1371/journal.pone.0021728.g006
Association between AGG and Transcription
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e21728compared FMR1 mRNA levels by the number of AGG
interruptions present in a given allele (Tassone et al., 2007).
However, given that the total CGG length, which is highly
predictive of FMR1 mRNA levels, differs significantly between
subjects with different number of AGG interruptions, further
analyses were conducted in which a separate linear regression of
FMR1 mRNA levels on total CGG length was fitted for each
number of AGG interruptions. When controlling for total CGG
length, the number of AGG interruptions does not appear to have
a meaningful impact on FMR1 mRNA levels.
Finally, we have analyzed the correlation of FMR1 mRNA
levels and age in premutation carriers. This analysis was
performed on both genders separately, and results were consistent
between genders, as no significant association was made between
age and mRNA level. Thus, the increase levels of FMR1 mRNA in
premutation carriers do not appear to change with time (either
increasing or decreasing). However, FMR1 transcript levels were
determined in total RNA isolated from peripheral blood
leukocytes. Thus, it is possible that the levels may change with
time in other tissues (i.e. brain).
In conclusion, we have demonstrated that the elevated FMR1
mRNA levels observed in premutation carriers, which are strongly
correlated to the CGG repeat number, are not affected by the
presence of the AGG interruption. Importantly we have shown
that the FMR1 mRNA levels in premutation carriers are not
influenced by the age of the subject. This is of relevance as
elevated levels of FMR1 mRNA have been demonstrated to be
causative or related not only to FXTAS, but also to the reported
behavioral problems, cognitive impairment and seizure observed
in early development in premutation carriers [27,29,30,35,36,37]
to autoimmune disorders in female premutation carriers
[38,39,40] and perhaps to the primary ovarian insufficiency
(FXPOI), observed in ,20% female carriers of a premutation
[23,24,41].
Thus, the elevated levels of FMR1 mRNA, which appear to not
change with time, are likely to be causative for both neurodevel-
opmental and neurodegenerative phenotypes in premutation
carriers throughout their life.
Materials and Methods
Subjects
Individuals were recruited through the M.I.N.D. Institute Clinic
and provided informed consent for participation. Individuals were
selected from fragile X pedigrees based on molecular testing
identifying a premutation size allele. None were selected on the
basis of clinical symptoms.
Blood was collected in EDTA (for DNA isolation) and Tempus
vacutainers (for total RNA isolation) under protocols approved by
the Institutional Review Board. Samples were chosen for inclusion
in this study based on the CGG repeat allele within the size range
of a premutation. In total, 770 DNA samples, comprising 288
Figure 7. Scatterplot of FMR1 mRNA levels by age. A linear regression model showed no significant relationship between FMR1 mRNA levels
and age, controlling for CGG length, in a) males (P=0.093) or b) females (P=0.297).
doi:10.1371/journal.pone.0021728.g007
Table 2. Comparison of linear regression fits for FMR1 mRNA
levels by total CGG length.
Comparison P-Value, Males P-Value, Females
0 AGG vs. 1 AGG, Slope 0.046 0.637
0 AGG vs. 2 AGG, Slope 0.840 0.617
1 AGG vs. 2 AGG, Slope 0.101 0.449
0 AGG vs. 1 AGG, Intercept 0.191 0.626
0 AGG vs. 2 AGG, Intercept 0.708 0.642
1 AGG vs. 2 AGG, Intercept 0.185 0.448
doi:10.1371/journal.pone.0021728.t002
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repeats and 1 premutation allele (Allele 2) with 55 CGG repeats. Using a CCG chimeric primer, AGG interruptions can be identified as loss of signal
intensity spanning 5 CGG peaks, followed by restoration of signal intensity. AGG interruptions occurring in the normal allele have a loss of
approximately half the CGG peak intensity due to the presence of CGG peaks from the premutation allele. Allele 1: (CGG)10-AGG-(CGG)9-AGG-(CGG)9;
Allele 2: (CGG)9-AGG-(CGG)9-AGG-(CGG)35. b) PCR product using a GGC chimeric primer and the same DNA sample as Fig. 8a. AGG interruptions result
in loss of signal in 4 consecutive CGG peaks, followed by restoration in signal. Overlapping AGG interruptions results in peak intensity falling to
baseline levels.
doi:10.1371/journal.pone.0021728.g008
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characterized (including CGG repeat number, length of 39 pure
CGG stretch, activation ratio, FMR1 mRNA expression levels and
presence of AGG interruptions).
Molecular measures
CGG repeat size. Genomic DNA (gDNA) was isolated from
5 mL of peripheral blood leukocytes using Gentra Puregene Blood
Kit (Qiagen). gDNA was used to determine the size of the CGG
repeat allele, methylation status and the FMR1 activation ratio in
females by Southern Blot analysis and PCR amplification, using
established diagnostic protocols [42].
FMR1 mRNA levels. Total RNA was isolated from whole
blood collected in Tempus vacutainers (Applied Biosystems).
Reverse transcription followed by real time PCRs (qRT-PCR) to
measure the FMR1 transcript levels were performed on total RNA
samples, as previously described [9].
The relative abundance of FMR1 mRNA was assessed using the
b-glucoronidase (GUS) mRNA as a reference gene. For each
sample, RT reactions were run starting from 3 different total RNA
concentrations (500–250 and 125 ng) and quantitative-PCR
reactions were performed for both FMR1 and GUS amplicons
for a total of 12 reactions. Control reactions (FMR1 and GUS) were
run in parallel with total RNA isolated from a standard control
lymphoblastoid used as a calibrator (RPM 7666; ATCC
CCL114]). Details of the methodology and analysis are as
described in [9].
AGG interruptions. A PCR approach including a CGG
repeat primer, as previously described [35,42] was used to
determine the number and the distribution of AGG interrup-
tions within the FMR1 gene. PCR was performed using 100 ng of
gDNA following manufacturer’s recommendations (Asuragen) and
as described in Chen et al., [35]. The presence and the distribution
of AGG interruptions was determined by the analysis of an
electropherogram as illustrated in Figure 8a and in Figure S4.
Briefly, a three primer assay is designed to amplify the 239 bp
flanking region of the trinucleotide repeat (using c and f primers)
[43], resulting in a PCR fragment corresponding to the CGG
repeat size. The third primer, a CGG chimeric primer (CCG)5
which anneals to CGG tracts, amplifies intermediate fragments
that are variable in length. The chimeric primer is unable to
anneal to a CGG tract that is interrupted with an AGG, this allows
the location of interruptions to be mapped by identification of a
corresponding absence of PCR product.
gDNA was amplified in a 15 ml total reaction volume using
ABI GeneAmp 9700 (Applied Biosystems) under the following
conditions: 95uC for 5 minutes; followed by 10 cycles of 97uCf o r
35 seconds, 62uC for 35 seconds, 68uC for 4 minutes; 20 cycles of
97uC for 35 seconds, 62uC for 35 seconds, 68uC for 4 minutes
and an additional 20 seconds per cycle; 72uC extension for
10 minutes and finally incubation at 4uC. Two microliters of
PCR product was denatured with 2 mL of ROX 1000 size marker
(Asuragen) in Hi-Di Formamide (Applied Biosystems) to a total
volume of 15 mL for 2 minutes at 95uC followed by 3 minutes at
4uC. The single stranded amplified product was visualized by
capillary electrophoresis using the ABI 3100 Genetic Analyzer
(Applied Biosystems). Fragments were separated through a 36-cm
capillary array using POP4 polymer (Applied Biosystems)
following manufacturers recommendations with the following
changes to the default run parameters: injection for 20 seconds at
1250 volts, and a run time of 50 minutes. AGG positions within
the CGG element were determined from raw Genescan files
imported into Peakscanner software (v1.0) (Applied Biosystems).
FAM-6 labeled PCR product is displayed as an electrophero-
gram. The full fragment visualized as a distinct band(s) amplified
by the c and f primers is first identified and sized using the size
standard marker (Asuragen). The CGG linker primer generates
PCR fragments that are smaller than the sizing amplicons and
are varying in size. They are identified on Peakscanner as peaks
with lower signal intensity than sizing peaks of normal range
alleles and are smaller fragment lengths than sizing peak that
correspond to the same allele. The presence of an AGG
interruption can be visualized on the electropherogram as a loss
of signal intensity spanning 5 CGG peaks, followed by the
restoration of signal intensity (Figure 8a,b). These 5 peaks
correspond to the positions of the AGG interruption and 4 CGG
segments up and downstream of the AGG interruption. Similarly,
the first CGG peak on the electropherogram is the 5
th CGG
repeat of the amplicon, the first 5 repeats being the earliest
position on the DNA template for the CGG linker primer to
anneal. To characterize the CGG tract the peaks and dips are
ordered in reverse of their position on the electropherogram,
given the directionality of the f and CGG linker primers. AGG
interruptions are expected at the far end of the electropherogram,
where signal intensity naturally decreases from longer PCR
amplification being less thermodynamically favorable than
shorter fragments.
A sample set including 47 DNAs underwent an additional PCR
step to confirm the position of the AGG interruption using a
(GGC)4 chimeric primer as described in Tassone et al., [42]
(Figure 8b). In this case the linker anneals to the CGG tract on
the reverse strand, and only requires 4 uninterrupted repeats.
This primer amplifies in conjunction with the c primer, creating
the same AGG interruption dips that were previously seen at the
tail end of the electropherogram but now visualized at the
beginning of the electropherogram with the highest signal
intensity. It is to be noted that potential ambiguity of AGG
position may exist in female samples in cases where the location
of the AGG interruption could be attributed to the same position
of both alleles (normal and premutation). There is a small risk for
AGG interruptions of the premutation allele to be incorrectly
interpreted as being present on the normal allele in females. The
ambiguity of one AGG interruption in a location where two
CGG repeat sequences overlap can typically be resolved in
premutation carriers using the CGG linker because interruptions
are expected to occur at the 39 end of the CGG repeat. The
CGG linker assay amplifies the 59 end of the CGG repeat first
which provides a length of space between the AGG interruptions
on a premutation allele with the AGG interruptions of a normal
allele. The cases where this may not be true are when the
premutation allele is a low premutation and the normal is a high
normal, also many AGG interruptions will decrease the space
between premutation and normal AGG interruption ranges, and
very rare AGG interruption patterns that are located more than
20 repeats from the 39 end of the CGG repeat. In order to resolve
these ambiguous female premutation carrier samples the typical
CGG linker assay was used and the presence or absence of AGG
interruptions was determined by digest with EciI as previously
described [10].
Supporting Information
Figure S1 Distribution of age in participants. The
distribution of ages in a) males and b) females.
(TIFF)
Figure S2 Distribution of FMR1 mRNA levels. Distribu-
tions of FMR1 mRNA levels in a) males and b) females.
(TIFF)
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gene. Distributions of FMR1 CGG repeats are similar in a) males
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Figure S4 Electropherogram of FMR1 CGG linker PCR.
PCR product from a premutation female with 1 normal allele
(Allele 1) with 2 AGG interruptions in 30 CGG repeats and 1
premutation allele (Allele 2) with 2 AGG interruptions in 87 CGG
repeats. Determination of the number and location of the AGG
interruptions within each allele was performed as described in the
method section.
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